<div dir="ltr">News from IPATH. <br><br clear="all"><div><div dir="ltr" class="gmail_signature" data-smartmail="gmail_signature"><div dir="ltr"><div><div dir="ltr"><div><div dir="ltr"><div dir="ltr">-Michelle W5NYV<br><br><div dir="ltr"><br></div></div></div></div></div></div></div></div></div><br><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">---------- Forwarded message ---------<br>From: <strong class="gmail_sendername" dir="auto">Lampley, Elizabeth</strong> <span dir="auto"><<a href="mailto:elampley@health.ucsd.edu">elampley@health.ucsd.edu</a>></span><br>Date: Fri, Jul 23, 2021 at 10:28 AM<br>Subject: New Phage Therapy Study Group under ESCMID<br>To: <a href="mailto:ipath-journal-club-l@ucsd.edu">ipath-journal-club-l@ucsd.edu</a> <<a href="mailto:ipath-journal-club-l@ucsd.edu">ipath-journal-club-l@ucsd.edu</a>><br></div><br><br>
<div lang="EN-US" link="#0563C1" vlink="#954F72" style="word-wrap:break-word">
<div class="m_-8213222490896799335WordSection1">
<p class="MsoNormal">Dear All, <u></u><u></u></p>
<p class="MsoNormal">We are excited to share that a new study group focused on phage therapy (and other non-traditional antibacterial therapy) has been created under the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal"><b>A description of the study group and how to join is provided below:
<u></u><u></u></b></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal" style="margin-bottom:8.0pt"><span lang="EN-GB">ESGNTA (ESCMID Study Group for Non-Traditional Antibacterial Therapy) aims to explore non-traditional antibacterials including bacteriophage, antimicrobial phage and phage-related products
for therapy, as well as increase and support the knowledge in phage lysin and other protein research and understanding carriers and applications optimal for use in clinical settings (ex: gel, nanoparticles, etc.).</span><u></u><u></u></p>
<p class="MsoNormal"><span lang="EN-GB"> </span><u></u><u></u></p>
<ul style="margin-top:0in" type="disc">
<li class="m_-8213222490896799335MsoListParagraph" style="margin-bottom:8.0pt;margin-left:0in">
<span lang="EN-GB">To join the group, you must be an ESCMID member which you can sign up <a href="https://urldefense.com/v3/__https:/www.escmid.org/membership_organisation/membership/membership_application/personal_data/__;!!LLK065n_VXAQ!3Ey4uWcBr35xHXKRCzSyFBbGny1DlJiKwj0IkqeacGuPRL7PwZKjaURdi-vZ3LarGl0$" target="_blank">here</a>.
During the registration process you can select which Study Groups you want to join, as you are allowed to join any that match your personal interests.</span><u></u><u></u></li></ul>
<p class="MsoNormal" style="text-indent:2.25pt"><u></u> <u></u></p>
<ul style="margin-top:0in" type="disc">
<li class="m_-8213222490896799335MsoListParagraph" style="margin-bottom:8.0pt;margin-left:0in">
<span lang="EN-GB">If you are already an ESCMID member, then you can sign up for Study Groups <a href="https://urldefense.com/v3/__https:/www.escmid.org/research_projects/study_groups/become_sg_member/__;!!LLK065n_VXAQ!3Ey4uWcBr35xHXKRCzSyFBbGny1DlJiKwj0IkqeacGuPRL7PwZKjaURdi-vZRrqM7zQ$" target="_blank">here</a> which
you can select ESGNTA from the list during the application process.</span><u></u><u></u></li></ul>
<p class="MsoNormal" style="text-indent:2.25pt"><u></u> <u></u></p>
<ul style="margin-top:0in" type="disc">
<li class="m_-8213222490896799335MsoListParagraph" style="margin-bottom:8.0pt;margin-left:0in">
<span lang="EN-GB">You can visit the website of ESGNTA to learn more about its mission and objectives as well as the bylaws of the Study Group
<a href="https://urldefense.com/v3/__https:/www.escmid.org/research_projects/study_groups/study_groups_g_n/non_traditional_antibacterial_therapy/__;!!LLK065n_VXAQ!3Ey4uWcBr35xHXKRCzSyFBbGny1DlJiKwj0IkqeacGuPRL7PwZKjaURdi-vZTeDqkhI$" target="_blank">
here</a>.</span><u></u><u></u></li></ul>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal">We hope you are able to join, <u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal"><img border="0" width="96" height="96" style="width:1.0in;height:1.0in" id="m_-8213222490896799335Picture_x0020_1" src="cid:17ad4958bed4cff311"><u></u><u></u></p>
<p class="MsoNormal">The IPATH Team<u></u><u></u></p>
<p class="MsoNormal"><a href="mailto:ipath@health.ucsd.edu" target="_blank">ipath@health.ucsd.edu</a><u></u><u></u></p>
<p class="MsoNormal"><a href="https://medschool.ucsd.edu/som/medicine/divisions/idgph/research/center-innovative-phage-applications-and-therapeutics/Pages/default.aspx" target="_blank">ipath.ucsd.edu</a> <u></u><u></u></p>
</div>
</div>
<p></p>
-- <br>
You received this message because you are subscribed to the Google Groups "ipath-journal-club-l" group.<br>
To unsubscribe from this group and stop receiving emails from it, send an email to <a href="mailto:ipath-journal-club-l+unsubscribe@ucsd.edu" target="_blank">ipath-journal-club-l+unsubscribe@ucsd.edu</a>.<br>
</div></div>